Koyfin Home > Directory > Health Care > Aquestive Therapeutics Inc > Long-term Debt / Equity

Aquestive Therapeutics Inc Long-term Debt / Equity Chart (AQST)

Aquestive Therapeutics Inc annual/quarterly Long-term Debt / Equity from 2018 to 2018.
  • Aquestive Therapeutics Inc Long-term Debt / Equity for the quarter ending December 12, 2018 was $423m
  • Aquestive Therapeutics Inc Long-term Debt / Equity for the last 12 months ending December 12, 2018 was $423m
  • Aquestive Therapeutics Inc Annual Long-term Debt / Equity for 2018 was $423m a 69.95% increase of 296m from 2017
  • Aquestive Therapeutics Inc Annual Long-term Debt / Equity for 2005 was $127m
Other Ratios Metrics:
  • Aquestive Therapeutics Inc Total Debt / Capital for the quarter ending December 12, 2018 was $82m a -136.67% decrease of -113m year over year
  • Aquestive Therapeutics Inc Other Liabilities for the quarter ending December 12, 2018 was $1m a -565.38% decrease of -7m year over year
  • Aquestive Therapeutics Inc Total Debt / Equity for the quarter ending December 12, 2018 was $468m
View Chart On Koyfin

Quarterly AQST Long-term Debt / Equity Data

12/2018$423m
09/2018$188m

Annual AQST Long-term Debt / Equity Data

2018$423m
2005$127m